Cargando…

Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria

OBJECTIVE: Antimalarial chemoprophylaxis for high risk groups in endemic areas of Southeast Asia has the potential to reduce malaria transmission and accelerate elimination. However, the optimal choice of medication and dosing for many potential candidates is not clear. For a planned randomised cont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tarning, Joel, von Seidlein, Lorenz, Dondorp, Arjen M., White, Nicholas J., Maude, Richard J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528175/ https://www.ncbi.nlm.nih.gov/pubmed/36184602 http://dx.doi.org/10.1186/s13104-022-06212-y

Ejemplares similares

Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
por: Peto, Thomas J, et al.
Publicado: (2022)

Study protocol: an open-label individually randomised controlled trial to assess the efficacy of artemether-lumefantrine prophylaxis for malaria among forest goers in Cambodia
por: Maude, Richard James, et al.
Publicado: (2021)

Artemether-lumefantrine co-administration with antiretrovirals: population pharmacokinetics and dosing implications
por: Hoglund, Richard M, et al.
Publicado: (2015)

Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
por: Ali, Shabana, et al.
Publicado: (2010)

Pharmacokinetic Properties of Artemether, Dihydroartemisinin, Lumefantrine, and Quinine in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria in Uganda
por: Tarning, Joel, et al.
Publicado: (2013)

Severe Acute Malnutrition Results in Lower Lumefantrine Exposure in Children Treated With Artemether‐Lumefantrine for Uncomplicated Malaria
por: Chotsiri, Palang, et al.
Publicado: (2019)

Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
por: Belew, Sileshi, et al.
Publicado: (2020)

Population Pharmacokinetics of Artemether, Dihydroartemisinin, and Lumefantrine in Rwandese Pregnant Women Treated for Uncomplicated Plasmodium falciparum Malaria
por: Lohy Das, Jesmin, et al.
Publicado: (2018)

Artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria
por: Ehrhardt, Stephan, et al.
Publicado: (2009)

Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis
por: Kloprogge, Frank, et al.
Publicado: (2018)

Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine
por: Walimbwa, Stephen I., et al.
Publicado: (2019)

Genomic Characterization of Recrudescent Plasmodium malariae after Treatment with Artemether/Lumefantrine
por: Rutledge, Gavin G., et al.
Publicado: (2017)

Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria
por: Tchaparian, Eskouhie, et al.
Publicado: (2016)

The Use of Artemether-Lumefantrine for the Treatment of Uncomplicated Plasmodium vivax Malaria
por: Bassat, Quique
Publicado: (2011)

Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India
por: Valecha, Neena, et al.
Publicado: (2009)

Artemether/Lumefantrine for the Treatment of P. malariae in a Patient on Hemodialysis
por: Patrocínio-Jesus, Rita, et al.
Publicado: (2019)

Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial
por: Tripura, Rupam, et al.
Publicado: (2023)

Effectiveness and safety of 3 and 5 day courses of artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in an area of emerging artemisinin resistance in Myanmar
por: Tun, Kyaw Myo, et al.
Publicado: (2018)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda
por: Zurovac, Dejan, et al.
Publicado: (2008)

Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial
por: Gürkov, Robert, et al.
Publicado: (2008)

Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?
por: Ogutu, Bernhards, et al.
Publicado: (2010)

Implementation of artemether-lumefantrine treatment policy for malaria at health facilities in Tanzania
por: Mugoyela, V, et al.
Publicado: (2011)

Monitoring the efficacy of artemether-lumefantrine for the treatment of uncomplicated malaria in Malawian children
por: Dambe, Rosalia, et al.
Publicado: (2015)

Efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Nepal
por: Ghimire, Prakash, et al.
Publicado: (2018)

The clinical efficacy of artemether/lumefantrine (Coartem(®))
por: Makanga, Michael, et al.
Publicado: (2009)

Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Malaria: A Randomized Trial
por: Kamya, Moses R, et al.
Publicado: (2007)

A Randomized Controlled Trial of Three- versus Five-Day Artemether-Lumefantrine Regimens for Treatment of Uncomplicated Plasmodium falciparum Malaria in Pregnancy in Africa
por: Onyamboko, Marie A., et al.
Publicado: (2020)

Quality of fixed dose artemether/lumefantrine products in Jimma Zone, Ethiopia
por: Belew, Sileshi, et al.
Publicado: (2019)

The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data
por: Bretscher, Michael T., et al.
Publicado: (2020)

A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia
por: Chanda, Pascalina, et al.
Publicado: (2007)

Possible Clinical Failure of Artemether-Lumefantrine in an Italian Traveler with Uncomplicated Falciparum Malaria.
por: Repetto, Ernestina C., et al.
Publicado: (2011)

Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients
por: Staehli Hodel, Eva Maria, et al.
Publicado: (2013)

Therapeutic efficacy of artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Benin
por: Ogouyèmi-Hounto, Aurore, et al.
Publicado: (2016)

CYP2B6*6 Genotype Specific Differences in Artemether‐Lumefantrine Disposition in Healthy Volunteers
por: Abdullahi, Sa'ad T., et al.
Publicado: (2019)

Limitations of malaria reactive case detection in an area of low and unstable transmission on the Myanmar–Thailand border
por: Parker, Daniel M., et al.
Publicado: (2016)

Provider knowledge of treatment policy and dosing regimen with artemether-lumefantrine and quinine in malaria-endemic areas of western Kenya
por: Watsierah, Carren A, et al.
Publicado: (2012)

Correct dosing of artemether-lumefantrine for management of uncomplicated malaria in rural Tanzania: do facility and patient characteristics matter?
por: Masanja, Irene M, et al.
Publicado: (2013)

Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos
por: Mayxay, Mayfong, et al.
Publicado: (2012)

Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults
por: Byakika-Kibwika, Pauline, et al.
Publicado: (2012)

A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya
por: Juma, Elizabeth A, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ppl1ont1lgplgafn5ehjn1j5jc